MENU
+Compare
IMRN
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$1.85
Change
-$0.03 (-1.60%)
Capitalization
9.3M

IMRN Immuron Limited Forecast, Technical & Fundamental Analysis

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis... Show more

Industry: #Biotechnology
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IMRN with price predictions
Jun 27, 2025

Momentum Indicator for IMRN turns positive, indicating new upward trend

IMRN saw its Momentum Indicator move above the 0 level on June 20, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 121 similar instances where the indicator turned positive. In of the 121 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for IMRN just turned positive on June 20, 2025. Looking at past instances where IMRN's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

IMRN moved above its 50-day moving average on June 20, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IMRN crossed bullishly above the 50-day moving average on June 26, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMRN advanced for three days, in of 169 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

IMRN broke above its upper Bollinger Band on June 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.572) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). IMRN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (2.474) is also within normal values, averaging (252.247).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMRN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Chapman Street
Phone
+61 398245254
Employees
6
Web
https://www.immuron.com.au
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLS152.672.52
+1.68%
Celestica
AUTL2.31N/A
N/A
Autolus Therapeutics plc
POLA1.73N/A
-0.12%
Polar Power Inc
EVO4.16-0.06
-1.42%
Evotec SE
TSAT24.04-0.46
-1.88%
Telesat Corp

IMRN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRN has been closely correlated with RIGL. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMRN jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRN
1D Price
Change %
IMRN100%
-1.60%
RIGL - IMRN
82%
Closely correlated
+3.73%
CLNN - IMRN
80%
Closely correlated
-4.08%
HOOK - IMRN
79%
Closely correlated
N/A
AZTR - IMRN
72%
Closely correlated
-0.69%
PHIO - IMRN
72%
Closely correlated
-1.81%
More

Groups containing IMRN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRN
1D Price
Change %
IMRN100%
-1.60%
IMRN
(2 stocks)
27%
Poorly correlated
+1.07%